"We conditionally recommend against methotrexate in breastfeeding women." "We strongly recommend that TNF-inhibitors as a class are compatible with breastfeeding." -Reproductive issues in RA #ACR18 @RheumNow

SLE pregnancy mgmt: 1) check anti-SSA/Ro and anti-SSB/La, APS antibodies once, check SLE activity every trimester #ACR18 @RheumNow

SLE pregnancy mgmt: 2) mgmt & prevention of SLE activity, including immunosuppressants (use AZA instead of MMF, etc.) #ACR18 @RheumNow

SLE pregnancy mgmt: 2) refer to MFM given high risk OB/pregnancy.... Continue HCQ! #ACR18 @RheumNow

SLE mgmt: HCQ and AZA compatible with breastfeeding... MMF not! #ACR18 @RheumNow

Men on MTX: conditionally recommend to continue MTX prior to conception (low level evidence). #ACR18 @RheumNow

Abstract 2587 Both TNFi and MTX demonstrated HbA1c reductions in DM pts with inflammatory arthropathies #ACR18 @rheumnow https://t.co/we0LltxTUV

AbstractL02 Small sample of pts had clinical and steroid tapering benefit after Tofacitinib Tx in open label dermatomyositis study #ACR18 @rheumnow https://t.co/7Sg9DqXpJB

For joint replacement surgery, how long do you hold tofacitinib?

Why was TENS more effective for FM in this study vs previous studies? Leslie Crofford: “All TENS is not the same“ - they will publish their parameters when final study is published. #ACR18 @RheumNow

Probably the first ever reference to Harold and Kumar at an ACR? No-one can accuse either side of being staid in the medical marijuana debate at #ACR18 5T119 @RheumNow

New DCVAS criteria for large vessel vasculitis help capture patients from all across the world, not just North America. "Infectious diseases can be geographic, while rheumatologic diseases can be demographic." - Me @RheumNow #ACR18

Dr. Ferucci on Rheumatology telemedicine in rural native clinics in Alaska: initial visit is still in person to establish a baseline and perform a physical exam. Best uses for TeleRheumatology and challenges (see slides) #ACR18 @RheumNow https://t.co/LeBsPzlZxP

#ACR18 Late Breaking: #L19 Crofford - Active vs placebo TENS vs no TENS for pain & fatigue in #fibromyalgia. TENS superior for pain & fatigue. >30% pain reduction in 44% TENS vs 22% PBO TENS vs 14% no TENS. Safe. Surprising but exciting to see TENS back for FM. @RheumNow https://t.co/a3qSWQBbqY

Tanezumab sc (anti-nerve growth factor) interesting for OA knee and hip, but the added elective joint replacements without radiographic differences between groups remains unexplained. More safety data on the way #ACR18 ABSTL20 @RheumNow